Literature DB >> 19534554

Multiple triphenylphosphonium cations shuttle a hydrophilic peptide into mitochondria.

Shareefa E Abu-Gosh1, Netanel Kolvazon, Boaz Tirosh, Israel Ringel, Eylon Yavin.   

Abstract

A variety of diseases are related to mitochondrial dysfunction. Hence, the ability to transport drugs to mitochondria that are otherwise cell impermeable would be of great therapeutic potential. Triphenylphosphonium (TPP) cations have been shown to accumulate in mitochondria when attached to small molecules. Here we report on the consequence of increasing the number of TPP moieties that are covalently linked to a model hydrophilic peptide Hemagglutinin A (HA). By extending the HA peptide with l-lysine amino acids to which the TPP's are covalently linked through the epsilon-amine, we have systematically synthesized the HA peptide with 0-3 TPP's. All peptides were subsequently labeled with FITC at the N-terminus. Cellular uptake and mitochondrial localization of the HA-TPP conjugates in HeLa cells were profoundly augmented with increasing number of TPPs, suggesting that this approach is applicable for the delivery of peptides. Furthermore, confocal microscopy demonstrated that the peptides localize to mitochondria. Importantly, all peptide conjugates did not show apparent toxicity at concentrations that are several orders of magnitude higher than those used for HA peptide delivery.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19534554     DOI: 10.1021/mp900032r

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  8 in total

1.  Multiple triphenylphosphonium cations as a platform for the delivery of a pro-apoptotic peptide.

Authors:  Netanel Kolevzon; Uriel Kuflik; Miriam Shmuel; Sandrine Benhamron; Israel Ringel; Eylon Yavin
Journal:  Pharm Res       Date:  2011-06-02       Impact factor: 4.200

2.  A targetable fluorescent sensor reveals that copper-deficient SCO1 and SCO2 patient cells prioritize mitochondrial copper homeostasis.

Authors:  Sheel C Dodani; Scot C Leary; Paul A Cobine; Dennis R Winge; Christopher J Chang
Journal:  J Am Chem Soc       Date:  2011-05-12       Impact factor: 15.419

3.  Triphenylphosphonium Moiety Modulates Proteolytic Stability and Potentiates Neuroprotective Activity of Antioxidant Tetrapeptides in Vitro.

Authors:  Rezeda A Akhmadishina; Ruslan Garifullin; Natalia V Petrova; Marat I Kamalov; Timur I Abdullin
Journal:  Front Pharmacol       Date:  2018-02-19       Impact factor: 5.810

4.  Responsive hetero-organelle partition conferred fluorogenic sensing of mitochondrial depolarization.

Authors:  Zhongwei Xue; Hu Zhao; Jian Liu; Jiahuai Han; Shoufa Han
Journal:  Chem Sci       Date:  2016-11-08       Impact factor: 9.825

5.  Triphenylphosphonium-modified mitochondria-targeted paclitaxel nanocrystals for overcoming multidrug resistance.

Authors:  Xue Han; Ruijuan Su; Xiuqing Huang; Yingli Wang; Xiao Kuang; Shuang Zhou; Hongzhuo Liu
Journal:  Asian J Pharm Sci       Date:  2018-09-18       Impact factor: 6.598

6.  Synthesis, Characterization and Anticancer Efficacy Studies of Iridium (III) Polypyridyl Complexes against Colon Cancer HCT116 Cells.

Authors:  Biao Xie; Yi Wang; Di Wang; Xingkui Xue; Yuqiang Nie
Journal:  Molecules       Date:  2022-08-25       Impact factor: 4.927

7.  Triphenylphosphonium Modified Mesoporous Silica Nanoparticle for Enhanced Algicidal Efficacy of Cyclohexyl-(3,4-dichlorobenzyl) Amine.

Authors:  Ho-Joong Kim; Sung Tae Kim; Dae Beom Park; Hoon Cho; Md Asadujjaman; Jun-Pil Jee
Journal:  Int J Mol Sci       Date:  2022-10-07       Impact factor: 6.208

8.  Two-Photon Enzymatic Probes Visualizing Sub-cellular/Deep-brain Caspase Activities in Neurodegenerative Models.

Authors:  Linghui Qian; Cheng-Wu Zhang; Yanli Mao; Lin Li; Nengyue Gao; Kah-Leong Lim; Qing-Hua Xu; Shao Q Yao
Journal:  Sci Rep       Date:  2016-05-23       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.